Researcher biography

Kate Schroder heads the Inflammasome Laboratory at the Institute for Molecular Bioscience, University of Queensland, as an ARC Future Fellow. Kate's PhD studies defined novel macrophage activation mechanisms (awarded 2005). Her subsequent postdoctoral research identified surprising inter-species divergence in the inflammatory programs of human versus mouse macrophages. As an NHMRC CJ Martin Fellow in Switzerland, Kate then trained with the pioneer of inflammasome biology, Jürg Tschopp. Kate has authored more than 70 publications, featuring in journals such as Science, Cell, Nature Genetics, Nature Medicine and PNAS USA, and her work has been cited more than 10,000 times. She is the recipient of the 2014 Milstein Young Investigator Award, 2013 Tall Poppy Award, 2010 QLD Premier's Postdoctoral Award, and the 2008 Society for Leukocyte Biology's Dolph Adams Award. In addition to her role as an IMB Lab Head, Kate is the Deputy Director of the IMB Centre for Inflammation and Disease Research, and Associate Editor for international journals such as Journal of Immunology and Cell Death Discovery.


During injury or infection, our body's immune system protects us by launching inflammation. But uncontrolled inflammation drives diseases such as gout, diabetes, neurodegenerative disease and cancer. The Inflammasome Lab is defining the molecular and cellular processes of inflammation. We seek to unravel the secrets of inflammasomes – protein complexes at the heart of inflammation and disease – to allow for new therapies to fight human diseases.

The Inflammasome Laboratory integrates molecular and cell biology approaches with in vivo studies to gain a holistic understanding of inflammasome function during infection, and inflammasome dysfunction in human inflammatory disease. Current research interests include the molecular mechanisms governing inflammasome activity and caspase activation, the cellular mediators of inflammasome-dependent inflammation, and inflammasome suppression by autophagy and small molecule inhibitors.